4
Changes in Ownership
Voyager Therapeutics, Inc. Filed Acc 0001104659-24-005244
Chief Scientific Officer sold 1,266 shares at $7.18 ($9,090)
From the SEC's structured data for this filing
Trades in this filing
Carter Todd Alfred · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-17 | Sale : show line 1 in the form | −1,266 | $7.18 | $9,090 | 53,094 | D |
| Open-market sales · 1,266 sh · avg $7.18 · $9,090 | ||||||
Loading xslF345X05/tm243664-1_4seq1.xml…